Semaglutide New Drug Combo Well-Tolerated, Leads to Weight Loss

Combining an investigational agent, cagrilintide (Novo Nordisk), with semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, results in better weight reduction than semaglutide alone in folks with a physique mass index... Read more »